These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33281934)

  • 1. Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohort.
    Ditrich F; Blümel S; Biedermann L; Fournier N; Rossel JB; Ellinghaus D; Franke A; Stange EF; Rogler G; Scharl M;
    Therap Adv Gastroenterol; 2020; 13():1756284820959252. PubMed ID: 33281934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's Disease Candidate Gene Alleles Predict Time to Progression from Inflammatory B1 to Stricturing B2, or Penetrating B3 Phenotype.
    Pernat Drobež C; Ferkolj I; Potočnik U; Repnik K
    Genet Test Mol Biomarkers; 2018 Mar; 22(3):143-151. PubMed ID: 29446656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
    Cernoch PS; Fournier N; Zeitz J; Scharl M; Morell B; Greuter T; Schreiner P; Misselwitz B; Safroneeva E; Schoepfer AM; Vavricka SR; Rogler G; Biedermann L;
    Dig Dis Sci; 2020 Sep; 65(9):2654-2663. PubMed ID: 31797187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
    Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
    Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.
    Lovasz BD; Lakatos L; Horvath A; Szita I; Pandur T; Mandel M; Vegh Z; Golovics PA; Mester G; Balogh M; Molnar C; Komaromi E; Kiss LS; Lakatos PL
    World J Gastroenterol; 2013; 19(14):2217-26. PubMed ID: 23599648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
    Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
    Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.
    Bourgonje AR; Alexdottir MS; Otten AT; Loveikyte R; Bay-Jensen AC; Pehrsson M; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Karsdal MA; Faber KN; Mortensen JH; Dijkstra G
    Aliment Pharmacol Ther; 2022 Aug; 56(4):675-693. PubMed ID: 35661188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease.
    Ungaro RC; Hu L; Ji J; Nayar S; Kugathasan S; Denson LA; Hyams J; Dubinsky MC; Sands BE; Cho JH
    Aliment Pharmacol Ther; 2021 Jan; 53(2):281-290. PubMed ID: 33131065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study.
    Bernstein CN; Panaccione R; Nugent Z; Marshall DA; Kaplan GG; Vanner S; Dieleman LA; Graff LA; Otley A; Jones J; Buresi M; Murthy S; Borgaonkar M; Bressler B; Bitton A; Croitoru K; Sidani S; Fernandes A; Moayyedi P
    Inflamm Bowel Dis; 2024 Mar; ():. PubMed ID: 38537257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rolling phenotype in Crohn's disease.
    Irwin J; Ferguson E; Simms LA; Hanigan K; Carbonnel F; Radford-Smith G
    PLoS One; 2017; 12(4):e0174954. PubMed ID: 28384331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early surgery in Crohn's disease patients with entero-urinary fistulas: does it change the prognosis?
    Coelho R; Magro F; Silva M; Macedo G
    Scand J Gastroenterol; 2016; 51(6):679-83. PubMed ID: 26679346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA polymorphisms predict time to progression from uncomplicated to complicated Crohn's disease.
    Pernat Drobež C; Repnik K; Gorenjak M; Ferkolj I; Weersma RK; Potočnik U
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):447-455. PubMed ID: 29293112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitubercular Therapy Given to Differentiate Crohn's Disease From Intestinal Tuberculosis Predisposes to Stricture Formation.
    Gupta A; Pratap Mouli V; Mohta S; Kante B; Kalaivani M; Madhu D; Sahu P; Kumar S; Sharma R; Sahni P; Das P; Gupta SD; Makharia G; Kedia S; Ahuja V
    J Crohns Colitis; 2020 Nov; 14(11):1611-1618. PubMed ID: 32369567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease.
    Kohoutova D; Drahosova M; Moravkova P; Rejchrt S; Bures J
    BMC Gastroenterol; 2014 Dec; 14():190. PubMed ID: 25551469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
    Schoepfer AM; Flogerzi B; Seibold-Schmid B; Schaffer T; Kun JF; Pittet V; Mueller S; Seibold F
    Am J Gastroenterol; 2009 Oct; 104(10):2508-16. PubMed ID: 19532127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.
    Lo B; Vester-Andersen MK; Vind I; Prosberg M; Dubinsky M; Siegel CA; Bendtsen F; Burisch J
    J Crohns Colitis; 2018 Feb; 12(3):265-272. PubMed ID: 29506105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico Approach.
    Dovrolis N; Drygiannakis I; Filidou E; Kandilogiannakis L; Arvanitidis K; Tentes I; Kolios G; Valatas V
    Inflamm Bowel Dis; 2019 Jan; 25(2):217-225. PubMed ID: 30346536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence patterns after first resection for stricturing or penetrating Crohn's disease.
    Sachar DB; Lemmer E; Ibrahim C; Edden Y; Ullman T; Ciardulo J; Roth E; Greenstein AJ; Bauer JJ
    Inflamm Bowel Dis; 2009 Jul; 15(7):1071-5. PubMed ID: 19229992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of Crohn's disease phenotype over time.
    Ouaz A; Fekih M; Labidi A; Ben Mustapha N; Serghini M; Zouiten L; Boubaker J; Filali A
    Tunis Med; 2016 Jun; 94(6):167-170. PubMed ID: 28051217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.